Correction: Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism (Proc. Natl. Acad. Sci. U.S.A. (2015) 112 (E5308–E5317) DOI:10.1073/pnas.1514475112);Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 38, 2015, Pages E5308-E5317

  Prusiner, Stanley B ^a,b   Woerman, Amanda L ^a   Mordes, Daniel A ^c   Watts, Joel C ^a,b,i   Rampersaud, Ryan ^a   Berry, David B ^a   Patel, Smita ^a   Oehler, Abby ^b   Lowe, Jennifer K ^d   Kravitz, Stephanie N ^d   Geschwind, Daniel H ^d,e   Glidden, David V ^b   Halliday, Glenda M ^f   Middleton, Lefkos T ^g   Gentleman, Steve M ^h   Grinberg, Lea T ^a,b   Giles, Kurt ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF TORONTO   (Canada)

Author keywords

Neurodegeneration; Parkinson's disease; Strains; Synucleinopathies

Indexed keywords

ALPHA SYNUCLEIN; BRAIN EXTRACT; YELLOW FLUORESCENT PROTEIN; PRION; SNCA PROTEIN, HUMAN; UBIDECARENONE; UBIQUINONE;

ADULT; AGED; BRAIN HOMOGENATE; CELL BODY; CELL CULTURE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INCUBATION TIME; MALE; MIDDLE AGED; NERVE CELL; NERVE FIBER; NEUROTRANSMISSION; PARKINSONISM; PRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHY DRAGER SYNDROME; TRANSGENE; ANALOGS AND DERIVATIVES; ANIMAL; BRAIN; DEGENERATIVE DISEASE; EXON; FLUORESCENCE MICROSCOPY; GENETICS; HEK293 CELL LINE; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; PATHOLOGY; PHOSPHORYLATION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSGENIC MOUSE;

AGED; ALPHA-SYNUCLEIN; ANIMALS; BRAIN; EXONS; FEMALE; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NEURODEGENERATIVE DISEASES; PARKINSONIAN DISORDERS; PHOSPHORYLATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PRIONS; UBIQUINONE;

EID: 84942860108     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.2408899121     Document Type: Erratum

References (63)

1. Gajdusek DC, Gibbs CJ, Jr, Alpers M (1966) Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature 209(5025):794-796.
2. Gibbs CJ, Jr, Gajdusek DC (1982) An update on long-term in vivo and in vitro studies designed to identify a virus as the cause of amyotrophic lateral sclerosis, parkinsonism dementia, and Parkinson's disease. Adv Neurol 36:343-353.
3. Graham JG, Oppenheimer DR (1969) Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 32(1):28-34.
4. Papp MI, Kahn JE, Lantos PL (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 94(1-3):79-100.
5. Spillantini MG, et al. (1998) Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 251(3):205-208.
6. Tu PH, et al. (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann Neurol 44(3):415-422.
7. Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H (1998) α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple systematrophy. Neurosci Lett 249(2-3):180-182.
8. Spillantini MG, et al. (1997) Alpha-synuclein in Lewy bodies. Nature 388(6645):839-840.
9. Polymeropoulos MH, et al. (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276(5321):2045-2047.
10. Schrag A, Ben-Shlomo Y, Quinn NP (1999) Prevalence of progressive supranuclear palsy and multiple system atrophy: A cross-sectional study. Lancet 354(9192):1771-1775.
11. Bower JH, Maraganore DM, McDonnell SK, Rocca WA (1997) Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 49(5):1284-1288.
12. Gilman S, et al. (1999) Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 163(1):94-98.
13. Watts JC, et al. (2013) Transmission of multiple system atrophy prions to transgenic mice. Proc Natl Acad Sci USA 110(48):19555-19560.
14. Woerman AL, et al. (2015) Propagation of prions causing synucleinopathies in cultured cells. Proc Natl Acad Sci USA 112(35):E4949-E4958.
15. Gilman S, et al. (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9):670-676.
16. Wenning GK, Braune S (2001) Multiple system atrophy: Pathophysiology and management. CNS Drugs 15(11):839-852.
17. Yabe I, et al. (2006) MSA-C is the predominant clinical phenotype of MSA in Japan: Analysis of 142 patients with probable MSA. J Neurol Sci 249(2):115-121.
18. Wüllner U, et al. (2007) Features of probable multiple system atrophy patients identified among 4770 patients with parkinsonism enrolled in the multicentre registry of the German Competence Network on Parkinson's disease. J Neural Transm 114(9):1161-1165.
19. O'Sullivan SS, et al. (2008) Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 131(Pt 5):1362-1372.
20. Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C (2010) Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: A mutation update. Hum Mutat 31(7):763-780.
21. Scholz SW, et al. (2009) SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 65(5):610-614.
22. Kiely AP, et al. (2013) α-Synucleinopathy associated with G51D SNCA mutation: A link between Parkinson's disease and multiple system atrophy? Acta Neuropathol 125(5):753-769.
23. Lesage S, et al., French Parkinson's Disease Genetics Study Group (2013) G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndrome. Ann Neurol 73(4):459-471.
24. Pasanen P, et al. (2014) Novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology. Neurobiol Aging 35(9):2180.e1-2180.e5.
25. Multiple-System Atrophy Research Collaboration (2013) Mutations in COQ2 in familial and sporadic multiple-system atrophy. N Engl J Med 369(3):233-244.
26. Combarros O, Infante J, Llorca J, Berciano J (2003) Interleukin-1A (-889) genetic polymorphism increases the risk of multiple system atrophy. Mov Disord 18(11):1385-1386.
27. Infante J, Llorca J, Berciano J, Combarros O (2005) Interleukin-8, intercellular adhesion molecule-1 and tumour necrosis factor-alpha gene polymorphisms and the risk for multiple system atrophy. J Neurol Sci 228(1):11-13.
28. Telling GC, et al. (1995) Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83(1):79-90.
29. Sacino AN, et al. (2014) Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice. Proc Natl Acad Sci USA 111(29):10732-10737.
30. Bartz JC, Kincaid AE, Bessen RA (2003) Rapid prion neuroinvasion following tongue infection. J Virol 77(1):583-591.
31. Gajdusek DC (1977) Unconventional viruses and the origin and disappearance of kuru. Science 197(4307):943-960.
32. Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216(4542):136-144.
33. Prusiner SB (2014) Madness and Memory (Yale Univ Press, New Haven, CT), p 344.
34. Walker LC, Jucker M (2015) Neurodegenerative diseases: Expanding the prion concept. Annu Rev Neurosci 38:87-103.
35. Prusiner SB, et al. (1983) Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35(2 Pt 1):349-358.
36. Han H, Weinreb PH, Lansbury PT, Jr (1995) The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: Is NAC a common trigger or target in neurodegenerative disease? Chem Biol 2(3):163-169.
37. Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 14(5):504-506.
38. Li JY, et al. (2008) Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 14(5):501-503.
39. Olanow CW, Prusiner SB (2009) Is Parkinson's disease a prion disorder? Proc Natl Acad Sci USA 106(31):12571-12572.
40. Mougenot A-L, et al. (2012) Prion-like acceleration of a synucleinopathy in a transgenic mouse model. Neurobiol Aging 33(9):2225-2228.
41. Luk KC, et al. (2012) Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice. J Exp Med 209(5):975-986.
42. Luk KC, et al. (2012) Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338(6109):949-953.
43. Sacino AN, et al. (2014) Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice. Acta Neuropathol 127(5):645-665.
44. Peelaerts W, et al. (2015) α-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522(7556):340-344.
45. Recasens A, et al. (2014) Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys. Ann Neurol 75(3):351-362.
46. Masuda-Suzukake M, et al. (2013) Prion-like spreading of pathological α-synuclein in brain. Brain 136(Pt 4):1128-1138.
47. Giasson BI, et al. (2000) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290(5493):985-989.
48. Shimura H, et al. (2001) Ubiquitination of a new form of α-synuclein by parkin from human brain: Implications for Parkinson's disease. Science 293(5528):263-269.
49. Fujiwara H, et al. (2002) alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4(2):160-164.
50. Krumova P, et al. (2011) Sumoylation inhibits α-synuclein aggregation and toxicity. J Cell Biol 194(1):49-60.
51. Telling GC, et al. (1996) Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev 10(14):1736-1750.
52. Giles K, et al. (2012) Identification of I137M and other mutations that modulate incubation periods for two human prion strains. J Virol 86(11):6033-6041.
53. Bernoulli C, et al. (1977) Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1(8009):478-479.
54. Gibbs CJ, Jr, et al. (1994) Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery. J Neurol Neurosurg Psychiatry 57(6):757-758.
55. Flechsig E, et al. (2001) Transmission of scrapie by steel-surface-bound prions. Mol Med 7(10):679-684.
56. Giles K, et al. (2008) Resistance of bovine spongiform encephalopathy (BSE) prions to inactivation. PLoS Pathog 4(11):e1000206.
57. Cotzias GC, Van Woert MH, Schiffer LM (1967) Aromatic amino acids and modification of parkinsonism. N Engl J Med 276(7):374-379.
58. National Research Council (2011) Guide for the Care and Use of Laboratory Animals (National Academies Press, Washington, DC), 8th Ed.
59. Alafuzoff I, et al. (2009) Staging/typing of Lewy body related alpha-synuclein pathology: A study of the BrainNet Europe Consortium. Acta Neuropathol 117(6):635-652.
60. Giasson BI, et al. (2002) Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein. Neuron 34(4):521-533.
61. Cabin DE, et al. (2002) Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci 22(20):8797-8807.
62. Kuo YM, et al. (2010) Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Hum Mol Genet 19(9):1633-1650.
63. Carlson GA, et al. (1986) Linkage of prion protein and scrapie incubation time genes. Cell 46(4):503-511.